Department of Anaesthesia and Intensive Care Medicine, Lapland Central Hospital, Rovaniemi, Finland.
Acta Anaesthesiol Scand. 2013 Aug;57(7):863-72. doi: 10.1111/aas.12133. Epub 2013 May 28.
Severe sepsis is one of the leading causes of acute kidney injury (AKI). Patients with sepsis-associated AKI demonstrate high-hospital mortality. We evaluated the incidence of severe sepsis-associated AKI and its association with outcome in intensive care units (ICUs) in Finland.
This was a predetermined sub-study of the prospective, observational, multicentre FINNAKI study conducted in 17 ICUs during 1 September 2011 and 1 February 2012. All emergency ICU admissions and elective admissions exceeding 24 hours in the ICU were screened for presence of severe sepsis and AKI up to 5 days in ICU. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria and severe sepsis according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) criteria.
Of the 2901 included patients, severe sepsis was diagnosed in 918 (31.6%, 95% confidence interval [CI] 29.9-33.4%) patients. Of these 918 patients, 488 (53.2% [95% CI 49.9-56.5%]) had AKI. The 90-day mortality rate was 38.1% (95% CI 33.7-42.5%) for severe sepsis patients with AKI and 24.7% (95% CI 20.5-28.8%) for those without AKI. After adjusting for covariates, KDIGO stage 3 AKI was associated with an increased risk for 90-day mortality with an adjusted odds ratio (OR) of 1.94 (95% CI 1.28-2.94), but stages 1 and 2 were not.
More than half of the patients with severe sepsis had AKI according to the KDIGO classification, and AKI stage 3 was independently associated with 90-day mortality.
严重脓毒症是急性肾损伤(AKI)的主要原因之一。脓毒症相关 AKI 患者的院内死亡率较高。我们评估了芬兰重症监护病房(ICU)中严重脓毒症相关 AKI 的发生率及其与结局的关系。
这是前瞻性、观察性、多中心 FINNAKI 研究的预定子研究,该研究于 2011 年 9 月 1 日至 2012 年 2 月 1 日在 17 个 ICU 进行。所有急诊 ICU 入院和 ICU 超过 24 小时的择期入院均筛查是否存在严重脓毒症和 ICU 内 5 天内 AKI。AKI 根据肾脏疾病:改善全球结果(KDIGO)标准定义,严重脓毒症根据美国胸科医师学院/危重病医学会(ACCP/SCCM)标准定义。
在纳入的 2901 例患者中,918 例(31.6%,95%置信区间[CI]29.9-33.4%)被诊断为严重脓毒症。在这些 918 例患者中,488 例(53.2%[95% CI 49.9-56.5%])患有 AKI。AKI 严重脓毒症患者 90 天死亡率为 38.1%(95% CI 33.7-42.5%),无 AKI 患者为 24.7%(95% CI 20.5-28.8%)。调整协变量后,KDIGO 第 3 期 AKI 与 90 天死亡率增加相关,调整后的优势比(OR)为 1.94(95% CI 1.28-2.94),但第 1 期和第 2 期则不然。
根据 KDIGO 分类,超过一半的严重脓毒症患者发生 AKI,AKI 第 3 期与 90 天死亡率独立相关。